Gabriel Brisou

1.1k total citations
20 papers, 425 citations indexed

About

Gabriel Brisou is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Gabriel Brisou has authored 20 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Gabriel Brisou's work include Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and Biosimilars and Bioanalytical Methods (3 papers). Gabriel Brisou is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and Biosimilars and Bioanalytical Methods (3 papers). Gabriel Brisou collaborates with scholars based in France, United States and Germany. Gabriel Brisou's co-authors include Bertrand Nadel, Ido Amit, Eyal David, Sandrine Sarrazin, Christophe Bordi, Orit Matcovitch-Natan, Alexander Mildner, Bérengère de Laval, Michael H. Sieweke and Julien Maurizio and has published in prestigious journals such as Blood, Nature Immunology and PLoS ONE.

In The Last Decade

Gabriel Brisou

17 papers receiving 422 citations

Peers

Gabriel Brisou
Nicole Fewings Australia
Marta Wagner Poland
Niklas Hagberg Sweden
Marta Cuenca Netherlands
Stefanie Bugl Germany
Doris Trapin Austria
Madlen Oelsner Germany
Hajime Yasuda Japan
Fréderic Vély France
Franziska Szelinski Germany
Nicole Fewings Australia
Gabriel Brisou
Citations per year, relative to Gabriel Brisou Gabriel Brisou (= 1×) peers Nicole Fewings

Countries citing papers authored by Gabriel Brisou

Since Specialization
Citations

This map shows the geographic impact of Gabriel Brisou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Brisou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Brisou more than expected).

Fields of papers citing papers by Gabriel Brisou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Brisou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Brisou. The network helps show where Gabriel Brisou may publish in the future.

Co-authorship network of co-authors of Gabriel Brisou

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Brisou. A scholar is included among the top collaborators of Gabriel Brisou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Brisou. Gabriel Brisou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Aymard, M., Morgane Cheminant, Roch Houot, et al.. (2024). Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy: A Descar-T Study By Lysa Group. Blood. 144(Supplement 1). 239–239.
4.
Riedell, Peter A., Krish Patel, Yasmin Karimi, et al.. (2024). Plamotamab: First Presentation of Subcutaneous Administration in a Phase 1 Dose Escalation Study in Heavily Pretreated R/R NHL Patients Who Had Prior CAR-T Cell Therapy. Blood. 144(Supplement 1). 4497–4497. 2 indexed citations
5.
Ysebaert, Loïc, Roch Houot, Olivier Casasnovas, et al.. (2023). Real-Word Experience of CAR T-Cells in Patients with Relapsed/Refractory Follicular Lymphoma : A Descart Registry Analysis from the Lysa. Blood. 142(Supplement 1). 296–296. 6 indexed citations
6.
Barba, Pere, Junichiro Yuda, Maria Lia Palomba, et al.. (2023). A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies. Blood. 142(Supplement 1). 3099–3099. 3 indexed citations
7.
Patel, Krish, Jean‐Marie Michot, Asher Chanan‐Khan, et al.. (2021). Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma. Blood. 138(Supplement 1). 2494–2494. 19 indexed citations
8.
Mossadegh‐Keller, Noushin, et al.. (2021). Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models. Frontiers in Immunology. 12. 8 indexed citations
9.
Schroers‐Martin, Joseph G., Joanne Soo, Gabriel Brisou, et al.. (2021). Tumor-Confirmed Follicular Lymphoma Mutations Are Detectable in Peripheral Blood Years Prior to Clinical Diagnosis. Blood. 138(Supplement 1). 709–709. 1 indexed citations
10.
Brisou, Gabriel, Bertrand Nadel, & Sandrine Roulland. (2021). The Premalignant Ancestor Cell of t(14;18)+ Lymphoma. HemaSphere. 5(6). e579–e579. 7 indexed citations
11.
Laval, Bérengère de, Julien Maurizio, Prashanth K. Kandalla, et al.. (2020). C/EBPβ-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells. Cell stem cell. 26(5). 657–674.e8. 239 indexed citations
12.
Schroers‐Martin, Joseph G., Joanne Soo, Gabriel Brisou, et al.. (2020). Recurrent Crebbp Mutations in Follicular Lymphoma Appear Localized to the Committed B-Cell Lineage. Blood. 136(Supplement 1). 30–31. 2 indexed citations
13.
Ranchon, Florence, Laure Huot, Isabelle Carpentier, et al.. (2020). Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects. PLoS ONE. 15(12). e0243309–e0243309. 4 indexed citations
14.
Brisou, Gabriel, Laurine Gil, Giulia Pagano, et al.. (2018). Desynchronization of the Germinal Center Dynamics and Remodeling of the Tumor Microenvironment Characterize KMT2D-Driven Lymphomagenesis. Blood. 132(Supplement 1). 670–670. 4 indexed citations
15.
Milpied, Pierre, Iñaki Cervera-Marzal, Bruno Tesson, et al.. (2018). Human germinal center transcriptional programs are de-synchronized in B cell lymphoma. Nature Immunology. 19(9). 1013–1024. 93 indexed citations
16.
Brisou, Gabriel, et al.. (2018). Follicular lymphoma. Hématologie. 24(S2). 25–34. 1 indexed citations
17.
Medves, Sandrine, Sophie Gazzo, Delphine Poncet, et al.. (2016). A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B‐cells. British Journal of Haematology. 174(1). 57–70. 15 indexed citations
18.
Brisou, Gabriel, Stéphane Dalle, Pascale Felman, et al.. (2014). Alarms and Parameters Generated by Hematology Analyzer: New Tools to Predict and Quantify Circulating Sezary Cells. Journal of Clinical Laboratory Analysis. 29(2). 153–161. 8 indexed citations
19.
Brisou, Gabriel, Lionel Karlin, Laure Lebras, et al.. (2013). Pregnancy and multiple myeloma are not antinomic. Leukemia & lymphoma. 54(12). 2738–2741. 9 indexed citations
20.
Brisou, Gabriel, Kheïra Beldjord, Nicolas Mounier, et al.. (2013). Prognostic Impact Of Somatic NOTCH2 Mutation In Splenic Marginal Zone Lymphoma. Blood. 122(21). 4247–4247. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Fewings Breakdown of academic impact, for papers by Marta Wagner Breakdown of academic impact, for papers by Niklas Hagberg Breakdown of academic impact, for papers by Marta Cuenca Breakdown of academic impact, for papers by Stefanie Bugl Breakdown of academic impact, for papers by Doris Trapin Breakdown of academic impact, for papers by Madlen Oelsner Breakdown of academic impact, for papers by Hajime Yasuda Breakdown of academic impact, for papers by Fréderic Vély Breakdown of academic impact, for papers by Franziska Szelinski
Rankless by CCL
2026